Based on new data about Amgen’s PCSK9 inhibitor cholesterol drug Repatha, CVS Health’s chief medical officer, Dr. Troyen Brennan, told Reuters that the number of patients eligible to use the drug could quadruple. He noted that the data — published in the New England Journal of Medicine and showing Repatha’s ability to reduce heart attack, stroke, heart disease deaths, chest pain hospitalizations and stent and bypass procedures by 15% — would need to be reviewed by heart experts. (Reuters)
Albertsons, Rite Aid, CVS, Walgreens and Walmart all saw significant rises in year-over-year satisfaction, with all advancing at least 3% year over year, according to the American Customer Satisfaction Index.
Northwestern Ohio’s The Courier is reporting that CVS Health president and CEO Larry Merlo delivered a speech at Ohio Northern University titled “Driving More Affordable, Accessible and Effective Care,” in which he noted the ways pharmacy can help drive down healthcare costs. He said that retail pharmacy will play a key role in combatting such issues as medication non-adherence and stepping into primary care. “Retail pharmacy is oftentimes the front door to health care,” he reportedly said. “It provides more opportunities to interact with patients than any other site of care.” (The Courier)
Target, J&J, Pfizer, Ahold USA and Cardinal Health also make Omni50, a listing of the top 50 corporate and government buyers of products and services from an inclusive supply chain throughout the country.
Move in 2014 led to reduced cigarette purchases across all retail settings, with those who purchased cigarettes exclusively at CVS Pharmacy 38% more likely stop buying cigarettes, according to research published in the American Journal of Public Health.